X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (947) 947
Publication (84) 84
Book Chapter (6) 6
Book Review (4) 4
Magazine Article (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (852) 852
glucosylceramidase - therapeutic use (562) 562
gaucher disease - drug therapy (522) 522
female (389) 389
index medicus (389) 389
male (353) 353
enzyme replacement therapy (296) 296
gaucher disease (286) 286
adult (284) 284
enzymes (259) 259
glucosylceramidase - genetics (236) 236
gaucher disease - genetics (204) 204
glucocerebrosidase (203) 203
child (189) 189
middle aged (189) 189
mutation (180) 180
animals (171) 171
glucosylceramidase - metabolism (169) 169
gaucher disease - enzymology (165) 165
gaucher's disease (164) 164
adolescent (162) 162
hematology (152) 152
gaucher disease - complications (141) 141
treatment outcome (132) 132
glucosylceramidase - administration & dosage (129) 129
gaucher disease - pathology (125) 125
gaucher disease - therapy (125) 125
child, preschool (124) 124
gaucher disease - diagnosis (118) 118
genetics & heredity (118) 118
glucosylceramidase (105) 105
biochemistry & molecular biology (103) 103
aged (101) 101
pediatrics (101) 101
gaucher-disease (97) 97
recombinant proteins - therapeutic use (97) 97
mice (96) 96
gaucher disease - blood (84) 84
replacement therapy (82) 82
disease (81) 81
imiglucerase (81) 81
health aspects (77) 77
type-1 (76) 76
parkinson's disease (75) 75
medicine, general & internal (73) 73
gaucher disease - metabolism (72) 72
medicine, research & experimental (72) 72
phenotype (72) 72
infant (71) 71
glucosylceramidase - deficiency (69) 69
deficiency (65) 65
macrophage-targeted glucocerebrosidase (65) 65
gaucher disease - physiopathology (64) 64
therapy (63) 63
analysis (62) 62
glucosylceramidase - adverse effects (62) 62
endocrinology & metabolism (61) 61
internal medicine (61) 61
lysosomal storage disorders (59) 59
neurosciences (59) 59
article (57) 57
hydrolases (57) 57
genotype (56) 56
young adult (56) 56
glucosylceramidase - antagonists & inhibitors (55) 55
medicine (55) 55
biopharmaceutics (53) 53
cells (52) 52
genetics (52) 52
medicine & public health (52) 52
research article (51) 51
diagnosis (49) 49
enzyme replacement therapy - methods (49) 49
alpha-synuclein (48) 48
cells, cultured (48) 48
proteins (48) 48
care and treatment (47) 47
mutations (47) 47
splenectomy (47) 47
follow-up studies (46) 46
glucosylceramidase - chemistry (46) 46
identification (46) 46
time factors (46) 46
1-deoxynojirimycin - analogs & derivatives (45) 45
biochemistry, general (45) 45
multidisciplinary sciences (45) 45
children (43) 43
lysosomal storage diseases (43) 43
magnetic resonance imaging (43) 43
parkinson disease - genetics (43) 43
pharmacology & pharmacy (42) 42
cell biology (41) 41
enzyme inhibitors - therapeutic use (41) 41
gaucher disease - classification (41) 41
n-butyldeoxynojirimycin (41) 41
risk factors (41) 41
acid beta-glucosidase (40) 40
fibroblasts (39) 39
gene (39) 39
glucosylceramides - metabolism (39) 39
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (879) 879
French (26) 26
Spanish (19) 19
German (5) 5
Japanese (4) 4
Polish (3) 3
Russian (3) 3
Danish (2) 2
Dutch (2) 2
Bosnian (1) 1
Chinese (1) 1
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2013, Volume 110, Issue 9, pp. 3537 - 3542
Mutations of GBA1, the gene encoding glucocerebrosidase, represent a common genetic risk factor for developing the synucleinopathies Parkinson disease (PD) and... 
Pathology | Enzymes | Gaucher disease | Lewy body disease | Central nervous system | Parkinson disease | Mice | Alzheimers disease | Genetic mutation | Dementia | Lysosomal storage diseases | Memory defect | MAPT | Mouse models | mouse models | TAU-SYNUCLEIN | lysosomal storage diseases | DEMENTIA | MULTIDISCIPLINARY SCIENCES | ALPHA-SYNUCLEIN | PATHOLOGY | CEREBROSPINAL-FLUID | DEFICIENCY | GENE | DISEASE | memory defect | MUTATIONS | LEWY BODIES | Glucosylceramidase - genetics | Humans | Memory | Brain - enzymology | tau Proteins - metabolism | Gaucher Disease - pathology | tau Proteins - chemistry | Psychosine - analogs & derivatives | Parkinsonian Disorders - drug therapy | Protein Structure, Quaternary | Gaucher Disease - physiopathology | alpha-Synuclein - genetics | Gaucher Disease - drug therapy | Disease Models, Animal | Gaucher Disease - enzymology | Parkinsonian Disorders - physiopathology | Dependovirus - metabolism | Brain - physiopathology | Psychosine - metabolism | Mice, Transgenic | Parkinsonian Disorders - enzymology | Glucosylceramidase - metabolism | Hippocampus - pathology | Hippocampus - metabolism | Animals | Glucosylceramidase - therapeutic use | Brain - pathology | Glucosylceramidase - administration & dosage | Hippocampus - physiopathology | alpha-Synuclein - metabolism | Parkinsonism | Care and treatment | Physiological aspects | Hydrolases | Gaucher's disease | Index Medicus | Biological Sciences
Journal Article
Journal Article
Bioconjugate Chemistry, ISSN 1043-1802, 03/2018, Volume 29, Issue 3, pp. 649 - 656
Enzymes are attractive as immunotherapeutics because they can catalyze shifts in the local availability of immunostimulatory and immunosuppressive signals.... 
Topical Review | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | CHEMISTRY, ORGANIC | LYSOSOMAL STORAGE DISEASES | BLOOD-BRAIN-BARRIER | CHEMISTRY, MULTIDISCIPLINARY | ANTITUMOR IMMUNE-RESPONSES | ACUTE LYMPHOBLASTIC-LEUKEMIA | REPLACEMENT THERAPY | FUSION PROTEIN | ADENOSINE-DEAMINASE DEFICIENCY | POLYETHYLENE-GLYCOL | EXTRACELLULAR-SUPEROXIDE DISMUTASE | TARGETED DELIVERY | Glucosylceramidase - chemistry | alpha-Galactosidase - therapeutic use | Immunotherapy - methods | Humans | Anti-Inflammatory Agents - immunology | Antineoplastic Agents - therapeutic use | Asparaginase - chemistry | Gaucher Disease - therapy | Enzymes, Immobilized - immunology | Enzyme Therapy - methods | Immunoconjugates - immunology | alpha-Galactosidase - chemistry | Neoplasms - therapy | Lysosomal Storage Diseases - immunology | Anti-Inflammatory Agents - therapeutic use | Immunoconjugates - therapeutic use | Fabry Disease - immunology | alpha-Galactosidase - immunology | Asparaginase - therapeutic use | Enzymes, Immobilized - therapeutic use | Enzymes, Immobilized - chemistry | Biocatalysis | Lysosomal Storage Diseases - therapy | Antineoplastic Agents - immunology | Glucosylceramidase - immunology | Gaucher Disease - immunology | Glycosylation | Inflammation - immunology | Antineoplastic Agents - chemistry | Immunoconjugates - chemistry | Asparaginase - immunology | Inflammation - therapy | Animals | Anti-Inflammatory Agents - chemistry | Glucosylceramidase - therapeutic use | Neoplasms - immunology | Fabry Disease - therapy
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9645, pp. 1263 - 1271
Summary Gaucher's disease continues to be a model for applications of molecular medicine to clinical delineation, diagnosis, and treatment. Analyses of several... 
Internal Medicine | Gaucher Disease - physiopathology | Phenotype | Gaucher Disease - genetics | Glucosylceramidase - therapeutic use | Gaucher Disease - diagnosis | Humans
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 2010, Volume 44, Issue 1, pp. 41 - 47
Journal Article
Journal Article
Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2015, Volume 29, Issue 2, pp. 183 - 194
Journal Article